EMEA-000308-PIP01-08-M04
Key facts
Invented name |
MabThera
|
Active substance |
rituximab
|
Therapeutic area |
Oncology
|
Decision number |
P/0064/2019
|
PIP number |
EMEA-000308-PIP01-08-M04
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
|
Route(s) of administration |
|
Contact for public enquiries |
Roche Registration GmbH
Tel. +41 6169 79411 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-000308-PIP01-08-M04
|
Compliance opinion date |
29/05/2019
|
Compliance outcome |
positive
|